Please assess the completion status of the following clinical trial:

Trial Title: Registry of Use and Application of Sensor Augmented Pump (SAP) Therapy Under Daily Life Conditions

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients with signed informed consent~* Type 1 DM and has been on insulin pump therapy for at least 3 months prior to signature of the informed consent~* patients use CGM component as part as part of the continuous subcutaneous insulin infusion (CSII) therapy for a minimum of 1 month~Exclusion Criteria:~* participation in any other trial~* any disease or drug treatment that can interfere with the outcome of sensor usage~* using CGM in CSII \< 3 days/week~* patients not willing to sign informed consent~* abuse of alcohol or drugs (exception of nicotine consumption)~* eating disorder, anorexia, bulimia or other mental disorders

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Intervention Group (Type: None): Patients treated with sensor augmented pump (SAP) therapy with insulin pump Paradigm VEO® and use continuous glucose monitoring (CGM).

Based on this trial design, predict the completion outcome and termination type (if applicable).